Dilafor

Pharmaceutical company developing heparin derivatives with low anticoagulant activity

placeSolna, Stockholm County, Sweden calendar_todayFounded 2003 groups4 employees language dilafor.com

Innovation

13 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 493 times.

YearFilings
20155
20165
20175
20185
20191
20201
20214
20222
20234
20241
20252
20261

Investor mix

3 investors on record; lead investors include Opocrin, Rosetta Capital.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon